Recrutamento encerrado
FASE
Número Europeu 2015-003582-28
LOXO-TRK-15002 - NAVIGATE
A Phase 2 Basket Study of the Oral TRK Inhibitor Larotrectinib in Subjects With NTRK Fusion-positive Tumors
Detalhes
Destaques